Moderna, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Moderna, Inc. reported Cash And Cash Equivalents At Carrying Value of $2.60 billion for the year ending 2025.

  • Moderna, Inc. showed an increase of +34.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Moderna, Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
  • XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2015 to 2025), Moderna, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,531.6%.
  • Historical annual values: Fiscal year 2025: $2.60 billion | Fiscal year 2024: $1.93 billion | Fiscal year 2023: $2.91 billion | Fiscal year 2022: $3.21 billion | Fiscal year 2021: $6.85 billion | Fiscal year 2020: $2.62 billion | Fiscal year 2019: $236.00 million | Fiscal year 2018: $658.36 million | Fiscal year 2017: $134.86 million | Fiscal year 2016: $50.08 million | Fiscal year 2015: $159.04 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: